Get Your Personalized Supplement StackSupplement Stack Quiz

Lactobacillus Rhamnosus R0343nd

Also known as: Lactobacillus rhamnosus GG, LGG

Overview

*Lactobacillus rhamnosus* GG (LGG) is a lactic acid bacterium and a specific strain of the species *Lactobacillus rhamnosus*. It is predominantly used as a probiotic, particularly in fermented foods and dietary supplements, rather than being found in significant quantities in natural sources. LGG is well-known for its ability to endure harsh gastrointestinal conditions, promoting gut health and preventing gastrointestinal disorders. Extensive research involving randomized controlled trials and systematic reviews has been conducted around its effectiveness, showcasing its significant role in managing conditions such as antibiotic-associated diarrhea (AAD) and acute gastroenteritis.

Benefits

LGG has multiple evidence-backed benefits, including a notable reduction in the incidence of antibiotic-associated diarrhea (AAD), decreasing the risk from 22.4% to 12.3% (RR: 0.49, 95% CI: 0.29-0.83). Additionally, it shortens diarrhea duration in children suffering from acute gastroenteritis, with a mean difference of -0.85 days (95% CI: -1.15 to -0.56). Preliminary findings suggest that LGG may also aid in promoting oral tolerance in children with cow's milk allergy, achieving significant improvements (RR: 2.22, 95% CI: 1.86-2.66). While the evidence for treating infantile colic is inconclusive, LGG shows promise, particularly in pediatric populations.

How it works

LGG operates primarily through gastrointestinal colonization, reinforcing intestinal barrier functions, and modulating the immune response. It interacts with gut-associated lymphoid tissue (GALT), influencing cytokine production and increasing the expression of genes pertinent to immune function and barrier integrity. Its remarkable resilience to bile and acidic conditions allows LGG to survive and exert its effects in the intestines effectively.

Side effects

LGG is generally regarded as safe for diverse populations, including children and adults. Common side effects are not frequently reported, but some mild gastrointestinal symptoms, such as bloating or gas, may occur in less than 5% of users. Rare effects are not documented. Although drug interactions seem minimal, caution is advised for immunocompromised individuals. Pregnant or breastfeeding women should consult healthcare professionals before use, although LGG is typically safe for them too.

Dosage

The minimum effective dosage of LGG for preventing AAD and alleviating diarrhea duration starts at 10^10 CFU (colony-forming units) daily. Optimal dosages generally range from 10^10 to 10^11 CFU, while doses exceeding 10^11 CFU are usually unnecessary as no specific maximum safe limit has been established. For best outcomes, LGG should coincide with antibiotic administration for AAD prevention, and it is available in various forms, including capsules, powders, and fermented foods.

FAQs

Is LGG safe for everyone?

LGG is generally safe, but individuals with compromised immune systems should consult their healthcare provider prior to use.

When should I take LGG?

For optimal results, take LGG as directed, usually with meals to improve its survival through the stomach.

What results can I expect from using LGG?

Users can anticipate a lower risk of AAD and shorter durations of diarrhea if afflicted with acute gastroenteritis.

Is LGG a cure for digestive issues?

LGG is not a universal remedy; its benefits are localized to specific gastrointestinal conditions.

Research Sources

https://pubmed.ncbi.nlm.nih.gov/26365389/ – This systematic review and meta-analysis evaluated the efficacy of LGG in preventing antibiotic-associated diarrhea (AAD) and confirmed a significant reduction in risk among both children and adults (RR: 0.48, 95% CI: 0.26-0.89).
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2018.00124/full – This meta-analysis reported that LGG effectively reduced diarrhea duration in children with acute gastroenteritis (mean difference: -0.85 days, 95% CI: -1.15 to -0.56) by investigating numerous randomized controlled trials.
https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2021.727127/full – The study focused on the effects of LGG in promoting oral tolerance in children with cow's milk allergy, indicating a significant improvement in tolerance rates (RR: 2.22, 95% CI: 1.86-2.66) across the studies included.
https://pubmed.ncbi.nlm.nih.gov/39263298/ – This research provides insights into moderate evidence quality regarding LGG's effects in pediatric populations, noting variations in study designs and outcomes due to methodological limitations.
https://pubmed.ncbi.nlm.nih.gov/31025399/ – A comprehensive review that highlights the existence of both positive and inconclusive evidence on LGG’s effectiveness in treating infantile colic, calling for further high-quality trials to establish its efficacy.